First nationally-consistent list of hospital medicines takes effect in New Zealand

1 July 2013

People in New Zealand will be able to get the same medicines whichever hospital they visit, as a result of a new Hospital Medicines List (HML) in place across the country from July 1, says the country’s Pharmaceutical Management Agency PHARMAC.

Previously, some patients missed out on medicines that were used in some parts of the country but not others. That now changes with PHARMAC introducing the national hospital medicines list. The HML, similar to the community Pharmaceutical Schedule that PHARMAC also manages, includes the medicines that patients in all District Health Board hospitals will have access to.

“Today (July 1) marks a major milestone in improving patients’ access to DHB hospital medicines across the country,” says PHARMAC chief executive Steffan Crausaz, adding: “Developed by clinicians, pharmacists and PHARMAC over two years, the HML will be used for all DHB hospital prescribing, supporting the government’s goal of national and equitable access to hospital medicines regardless of where people live, and a consistent approach to the introduction of new pharmaceuticals in hospitals.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical